UNSPSC 51283219: Mepartricin b

This classification denotes a macrolide antibiotic with the molecular formula C59H86N2O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21G4VMN6C9, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin b, which bears US NIH Compound Identifier 6450330. European Medicines Agency schedules mepartricin b or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03153MIG.

Most nations, for tariff purposes, schedule mepartricin b under HS 29419000. SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC\2CC3C(C(CC(O3)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C)C(C)CCC(CC(=O)C4CCC(CC4)N)O)O)O)O)O)O)O)O)C(=O)OC)O)N)O.

UNSPSC 51283219 Mepartricin B is a Commodity code reflecting pharmaceutical and medical supply procurement by state and local health agencies, though recent solicitations tagged to this code diverge significantly from the nominal category name. State and local governments are actually buying naloxone kits, drug deactivation systems, emergency medical and first-aid supplies (including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, and oxygen delivery systems), and generic multi-source pharmaceuticals and over-the-counter products through this code. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (Tampa Fire Department), state health commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving participating state and local government facilities across multiple states including Oregon). The mix reflects both direct procurement by individual jurisdictions and aggregated purchasing through cooperative vehicles that serve multiple member agencies.

Recent activity concentrates in Florida and Texas, with broader multistate participation through the Minnesota cooperative. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building (response deadline July 26, 2023); the City of Tampa's IFB for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, designated as a sheltered market opportunity exclusively for certified Small Local Business Enterprises (SLBEs) with a 5 percent bid discount not to exceed $10,000 (response deadline March 13, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and over-the-counter products with proposals due March 26, 2026, requiring distribution through authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with awards effective July 1, 2026. Texas Health and Human Services Commission also issued an RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026), signaling emerging interest in alternative pharmacy supply models.